As WHO Approves Second Chinese Covid-19 Vaccine, ‘KMED’ Could Benefit
June 04, 2021 at 11:33 AM EDT
On Tuesday, the World Health Organization approved a Covid-19 vaccine produced by Sinovac Biotech for emergency use, the second vaccine created in China to be approved according to Reuters. That could be good news for the KraneShares Emerging Market Healthcare Index ETF (NYSE: KMED), which holds...
